Table 1. Values for jump height, creatine kinase, and muscle soreness score in the courses of the PESF and sham treatments.
| Pre | After run |
Δ | After 45 min |
Δ | 24 h After |
Δ | 48 h After |
Δ | ||
|---|---|---|---|---|---|---|---|---|---|---|
| Jump and reach (cm) | PESF | 276.2±8.7 | 273.0±7.0 | −3.3±3.9 | 273.0±10.5 | −3.3±3.6 | ||||
| Sham | 276.5±21.6 | 272.0±23.5 | −4.5±5.3 | 272.0±23.2 | −4.5±6.2 | |||||
| Creatine kinase (U/L) | PESF | 133.6±32.1 | 171.9±71.3 | 38.3±58.7 | ||||||
| Sham | 100.1±41.0 | 271.7±274.5 | 171.6±285.8 | |||||||
| Muscle soreness score | PESF | 1.4±1.4 | 3.6±1.7 | 2.1±2.0 | 4.0±2.0 | 2.6±1.6 | 5.1±0.9 | 3.7±1.6t | 4.6±1.5 | 3.1±2.0t |
| Sham | 1.0±1.0 | 4.0±1.4 | 3.0±1.7 | 4.1±1.7 | 3.1±2.2 | 6.7±1.7 | 5.7±2.2 | 6.4±2.4 | 5.4±3.2 | |
PESF: pulsating electrostatic field. The table represents values of the same participants receiving the PESF and sham treatments (n=7, crossover design). t There was a trend toward significant differences in delta values (Δ = after values (i.e. 45 min, 24 h, and 48 h after) minus pre value) between treatments (PESF vs. sham).